ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.53
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,344.72
0.90%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TherapeuticsMD Inc (TXMD)

  7. TherapeuticsMD Inc (TXMD) News

TherapeuticsMD (TXMD)

TherapeuticsMD Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TXMD
DateTimeSourceHeadlineSymbolCompany
10/05/202421:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
10/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
10/05/202421:05Business WireTherapeuticsMD Announces First Quarter 2024 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/03/202420:00Business WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
07/12/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
06/12/202316:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
17/11/202314:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
17/11/202314:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
14/11/202321:05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
21/08/202321:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
21/08/202321:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
18/08/202322:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
14/08/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
14/08/202312:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
14/08/202311:50Business WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
19/07/202322:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
19/07/202322:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
19/07/202322:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
10/07/202322:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
06/07/202321:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
30/06/202313:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
29/06/202322:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
29/06/202322:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
28/06/202312:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202322:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202322:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202321:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202321:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202321:05Business WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
05/05/202322:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
 Showing the most relevant articles for your search:NASDAQ:TXMD

Your Recent History

LSE
PET
Petrel Resources
LSE
SYME
Supply@me Capital
LSE
BIRD
Blackbird
LSE
GOLD
LSE
GFM
Griffin Mining
LSE
TERN
Tern
LSE
SCE
Surface Transforms
LSE
ITV
Itv
LSE
CNR
Condor Gold
LSE
SRSP
Sirius Petroleum
LSE
ALBA
Alba Mineral Resources
LSE
BBSN
Brave Bison
LSE
RKH
Rockhopper Exploration
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved